A Utah nutrition technology company achieves what few major global tech firms ever manage: three out of three “All-A, All-Yes” international search reports; WIPO published the applications today.
WOODS CROSS, UT, UNITED STATES, July 23, 2026 /EINPresswire.com/ — IndulgeRx Brands Inc. (“IndulgeRx”), a privately owned nutrition technology company backed by its founder, friends, and family, announced today that the World Intellectual Property Organization (WIPO) has officially made public all three of its Patent Cooperation Treaty (PCT) patent applications covering the AI-driven IRX FOODSCORE® platform. Every application individually received an “all-A” International Search Report (ISR) from the U.S. International Searching Authority (ISA/US), with all claims determined to be novel, inventive, and industrially applicable.
What Actually Happened
Every patent application in the AI or health-tech space undergoes examination by a professional patent searcher who searches globally for prior inventions that might block or duplicate the submitted claims. Citations receive grades: “X” indicates an invention-killer was discovered, “Y” means a combination of existing ideas could invalidate the claims, and “A” represents background context posing no real threat to patentability.
For all three IndulgeRx applications—covering the platform as a system, as software, and as a business method—the examiner located zero “X” and zero “Y” citations. Every reference came back as “A,” and each Written Opinion confirmed novelty, inventive step, and industrial applicability for claims 1–15.
The government (ISA) patent examiner’s own written conclusions highlight the result’s strength: even after combining every piece of prior art the examiner could locate, the reviewer determined that assembling them “would be impermissible hindsight”—patent terminology for reverse-engineering an answer only possible when looking backward. Additionally, where existing technology touched on isolated elements of the puzzle, the examiner found that combining them “would not provide any advantages over the present application, or would require a complexity beyond the level of ordinary skill.”
Each published application is now publicly accessible via WIPO PATENTSCOPE:
• IRX FS SOFTWARE – WO2026156106 A1
• IRX FS METHOD – WO2026156110 A1
• IRX FS SYSTEM – WO2026156104 A1
Voices Behind the Milestone
“For a nine-year, self-funded company to walk into the same global patent examination process that Google, Amazon, and Oracle face, and come out with a cleaner search result than most well-funded startups ever see, is validation money can’t manufacture,” said John L. Hastings III, CEO and Founder of IndulgeRx Brands Inc. “IRX FOODSCORE® isn’t a feature bolted onto someone else’s technology. It’s genuinely new, and now the world can see that for itself; changing the way the world eats, one byte at a time.”
“An independent patent examiner tested IRX’s technology against the biggest names in health AI, including Medtronic, Oracle, Salesforce, Cornell, and others, and could not identify any single reference or combination that defeats it,” said Richard D. Clarke, Esq., IndulgeRx’s patent counsel. “That is now a matter of public WIPO record, with a locked priority date of January 16, 2025 that predates every future copycat.” Patent counsel further notes one filing required a minor procedural claim-grouping clarification that did not affect the ‘A’ grades or any novelty findings, simply underscoring that this achievement rests on substance, not a technicality.
Why This Matters — For Every Kind of Investor
For IRX friends, family, and individual backers who funded this company from the beginning, this is independent, government-verified proof that a small, mission-driven team can out-innovate giants with far greater resources. For institutional investors and strategic acquirers, this milestone materially de-risks the IP moat underpinning IndulgeRx’s twelve monetizable vantage points: consumer apps, CPG licensing, retail, payers and providers, pharmacists, sports performance, researchers, and government agencies. It also strengthens the company’s value propositions and market positioning ahead of seed round and Series A investment discussions and strategic partnership conversations.
IRX FOODSCORE® analyzes an individual’s health history, age, gender, medications, and goals against ingredients, additives, preservatives, and preparation methods to generate two personalized numbers: a Relevant Nutrition Score (RNS) and a Relevant Risk Score (RRS), turning “is this good for me?” into one actionable IRX FOODSCORE® answer, anywhere in the world.
For more information about IndulgeRx Brands Inc. and IRX FOODSCORE®, visit www.indulgerx.com and www.indulgerx.com/irx-foodscore, or www.fightbackfoods.com.
Joe Darnell
IndulgeRx Brands, Inc
+1 801-683-8769
email us here
